Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial

Posted on June 26, 2025 by MissionIR
  • Lantern Pharma uses a proprietary AI platform, RADR®, to guide its oncology drug development, enabling rapid drug candidate identification and targeted trial design based on genomic and biomarker data.
  • A Phase 2 trial patient achieved a complete response in their primary cancer lesions after multiple prior therapies failed and has remained responsive to LP-300 for two years signaling durable clinical benefit in this challenging population.
  • The target population, never-smokers with non-small cell lung cancer, represents a growing global unmet need estimated at over $4 billion annually.

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with advanced non-small cell lung cancer (“NSCLC”) achieved a complete response using LP-300, a compound optimized through Lantern’s AI-powered platform, RADR(R) (https://ibn.fm/II6O6).

This outcome is particularly notable because the patient had previously undergone three unsuccessful lines of treatment, including immunotherapy and targeted kinase inhibitors. The patient’s sustained remission, now over two years, highlights the potential of AI-powered drug development to identify novel therapeutic opportunities for difficult-to-treat cancers.

RADR(R), short for Response Algorithm for Drug Positioning & Rescue, is Lantern’s proprietary platform for integrating large-scale genomic, biomarker, and preclinical data. The system is designed to uncover drug-cancer matches and synergistic combinations faster and more cost-effectively than traditional approaches. It was instrumental in advancing LP-300 by confirming its potential mechanism of action and compatibility with existing chemotherapy regimens.

In the HARMONIC(TM) trial, LP-300 is being tested in combination with pemetrexed and carboplatin, targeting never-smoker NSCLC patients who have progressed after prior kinase inhibitor therapy. The trial is randomized, open-label, and enrolling patients in the U.S., Japan, and Taiwan. With approximately 90 participants planned, the study compares LP-300 plus chemotherapy against chemotherapy alone.

The early signals are encouraging. Lantern’s lead-in cohort showed an 86% clinical benefit rate and a 43% objective response rate. In one case, a 70-year-old never-smoker with advanced disease showed a 57% tumor volume reduction in 2024. By early 2025, imaging confirmed a complete response in both lung and adrenal lesions. No dose-limiting toxicities or significant adverse reactions were reported over 21 cycles of treatment.

“This outcome provides important confirmation of our data and AI-driven approach to drug development and gives us growing confidence as we advance toward potential future registration-enabling studies for this underserved patient population that has no approved treatment options after failing targeted kinase therapies,” said Lantern CEO Panna Sharma, commenting on the results. “This remarkable case exemplifies several of the things we have hoped to observe with LP-300 in the HARMONIC trial. To see a heavily pre-treated patient not only achieve a complete response in their target cancer lesions but maintain that response with excellent quality of life is truly extraordinary,” Sharma added.

The never-smoker NSCLC population is clinically distinct. It has grown significantly over the past 30 years, from 15% to over 25% of lung cancer cases globally. In East Asia, never-smokers account for nearly 35% of new NSCLC diagnoses. Yet, no therapies are approved specifically for this subset of patients, despite the distinct molecular drivers and limited treatment options after failure of kinase targeted therapies. Lantern estimates this group represents a global market opportunity exceeding $4 billion annually.

RADR(R) was built to address exactly this kind of niche: genetically defined cancers with unmet needs. By leveraging machine learning, computationally-driven mechanistic biology, and biomarker discovery, Lantern is not only identifying drug candidates but also helping design trials that focus on populations most likely to benefit. According to the company, RADR(R) has processed over 200 billion oncology-specific data points to date, enabling the advancement of multiple clinical programs.

In addition to LP-300, Lantern’s pipeline includes two other small molecule candidates (LP-184, in a Phase 1a trial for advanced solid tumors and glioblastoma multiforme, and LP-284, in a Phase 1 trial for relapsed or refractory non-Hodgkin’s lymphoma and other solid tumors), an antibody-drug conjugate program, and programs in CNS and brain cancers. All of the programs are being developed using RADR(R) to streamline discovery and development timelines. The company is also engaged in research partnerships with academic institutions and global trial networks.

Clinical updates from the HARMONIC(TM) trial are expected through the second half of 2025 as enrollment progresses.

For more information, visit the company’s website at www.LanternPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to LTRN are available in the company’s newsroom at https://ibn.fm/LTRN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Lantern Pharma Inc. LTRN | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award

Posted on June 26, 2025 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the “Oscar of Italian Dermatology” from SIDeMaST for her research on PC111, a first-in-class anti-Fas Ligand monoclonal antibody. The study, published under the title “Blocking soluble Fas Ligand ameliorates pemphigus”, confirms PC111’s ability to block blister formation by preventing keratinocyte apoptosis in pemphigus vulgaris. Scinai holds an option to acquire Pincell and is advancing PC111 as a lead asset, emphasizing its potential as a non-immunosuppressive, disease-modifying treatment for severe autoimmune skin conditions.

To view the full press release, visit https://ibn.fm/Su4hS

About Scinai Immunotherapeutics Ltd.

Scinai is a biopharmaceutical company with two complementary business units. One is focused on in-house development of inflammation and immunology (“I&I”) biological therapeutic products beginning with an innovative, de-risked pipeline of nanosized VHH antibodies (“NanoAbs”) targeting diseases with large unmet medical needs. The second business unit is a boutique CDMO providing biological drug development, analytical methods development, clinical GMP manufacturing, and preclinical and clinical trial design and execution services to early stage biotech companies. For more information, visit the company’s website at www.Scinai.com.

NOTE TO INVESTORS: The latest news and updates relating to SCNI are available in the company’s newsroom at https://ibn.fm/SCNI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand

Posted on June 25, 2025 by MissionIR

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower access, private credit firms like FAVO Capital (OTC: FAVO) are emerging as essential players in the financial ecosystem. Leveraging scalable technology, a seasoned leadership team, and a growing syndication network, FAVO is positioning for growth at the intersection of market demand and digital transformation.

“At the heart of FAVO’s competitive advantage is its technology-focused lending model. The company continues to build and refine its proprietary CRM platform, which enables efficient underwriting, customer service, and deal syndication,” reads a recent article discussing the company. “In a digital-first lending landscape, that infrastructure is essential, not just for cost efficiency, but for maintaining relationships with borrowers in real time.”

To view the full article, visit https://ibn.fm/eSpQl

About FAVO Capital Inc.

FAVO Capital is a rapidly growing alternative finance company headquartered in Fort Lauderdale, Florida. The company offers personalized alternative finance solutions to emerging, small and medium-sized businesses. “FAVO” is “Honeycomb” in Latin – The Honeycomb (Hexagon) is the most efficient shape in the universe. FAVO intends to be efficient, flexible and durable. For more information visit www.FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in FAVO Capital Inc. FAVO | Leave a comment

Silvercorp Metals Inc. (NYSE-A: SVM) (TSX: SVM) Reports Record Q4 Results and Strong Cash Flow for Fiscal 2025

Posted on June 25, 2025 by MissionIR
  • Silvercorp’s Q4 revenue rose 76% year-over-year to $75.1 million.
  • Operating cash flow for the quarter reached $30.7 million, nearly tripling the $10.2 million reported in Q4 Fiscal 2024.
  • $13 million was invested into growth projects.
  • Even after investments made, Silvercorp added $14.5 million to cash, ending Fiscal 2025 with cash and short-term investments of $369.1 million.

Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc, with a long history of profitability, delivered its strongest fourth-quarter performance to date, closing out Fiscal 2025, ended March, with significant growth in both revenue and operating cash flow. The results reflect a combination of increased production volumes and stronger realized prices across the company’s key metals (https://ibn.fm/RuJVg).

Revenue for Q4 Fiscal 2025 reached $75.1 million, a 76% increase compared to $42.7 million in the same quarter last year. The growth was fueled by higher production—up 62% for gold and 42% for silver—and rising commodity prices, particularly a 33% increase in gold and 34% in silver.

Cash flow from operating activities was $30.7 million in the quarter, nearly tripling the $10.2 million reported in Q4 of the prior year. On a full-year basis, operating cash flow totaled $138.6 million.

Income from mine operations in the quarter climbed to $26.1 million, up from $13.0 million in Q4 Fiscal 2024. Silvercorp also increased capital investments in its core operations, spending $9.9 million in China and $3.1 million on its El Domo project in Ecuador during the quarter.

Even after these investments, the company added cash to its balance sheet and reported cash and short-term investments of $369.1 million, up from $354.6 million at the end of December 2024. It also held a $70.9 million portfolio of equity investments and has access to a $175 million stream financing credit to support El Domo mine construction.

To quickly summarize the full year results, just like the quarter, Fiscal 2025 was a record-breaking year across the board. As a growing and profitable silver producer that provides leverage to higher metals prices, these results reinforce why Silvercorp remains a compelling investment.

A clarification for investors is that, while earnings per share were slightly lower than some estimates, two accounting items contributed to this result. The first was a $20.6 million non-cash charge related to the fair value of derivative liabilities linked to the conversion rights of convertible notes and warrants. The second was a reclassification of certain mining preparation costs, which were expensed during the quarter. Neither of these items impacted cash flow.

The company completed its all-share acquisition of Adventus Mining Corporation during the fiscal year, adding the El Domo and Condor projects in Ecuador to its development pipeline.

Development efforts are progressing across multiple fronts. At the El Domo Copper-Gold Project, the company released an updated construction budget to $240.5 million, slightly below previous feasibility study estimate of $248 million. Production is expected to begin by the end of 2026.

Separately, an updated mineral resource estimate for the Condor Gold Project was released recently. The revised estimate will support a Preliminary Economic Assessment for a high-grade underground operation, expected to be completed later this year. In parallel, a 3,500-metre surface drilling campaign is now underway to refine exploration targets.

Silvercorp also declared a semi-annual dividend of US$0.0125 per share, payable by June 26, 2025, to shareholders of record, as of a June 6 announcement (https://ibn.fm/dtCfs).

With a growing portfolio of projects in Ecuador and China, and a disciplined approach to spending and development, Silvercorp remains focused on generating long-term shareholder value. Its 18-year track record of profitability, combined with a strong balance sheet and robust cash flows, offers a compelling opportunity for investors.

For more information, visit the company’s website at www.silvercorpmetals.com/welcome.

Third-Party Content Disclaimer

The IBN website may contain third-party content articles and other content submitted by third parties, including articles submitted through the IBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IBN providing you with this internet portal that makes accessible to you the ability to view third party content through the IBN site, IBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IBN expressly disclaims liability relating to such third-party content. IBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://IBN.fm/Disclaimer.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Silvercorp Metals Inc. SVM | Leave a comment

New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Is ‘One to Watch’

Posted on June 25, 2025 by MissionIR
  • New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, offering substantial resource potential and long-term production growth.
  • The company’s projects demonstrate strong economic fundamentals, with high internal rates of return and low all-in sustaining costs per ounce of silver.
  • Bolivia’s underexplored mineral potential presents a strategic advantage for New Pacific Metals, allowing it to capitalize on a historically rich mining region.
  • The company is backed by two strategic shareholders: Silvercorp Metals (28%) and Pan American Silver (12%).
  • The company is supported by an experienced leadership team with a track record of success in mineral exploration, development, and corporate finance.
  • As global silver demand increases for industrial and renewable energy applications, New Pacific Metals is well-positioned to benefit from market growth and rising silver prices.

New Pacific Metals (NYSE American: NEWP) (TSX: NUAG) is a Canadian exploration and development company focused on advancing world-class silver projects in Bolivia. The company’s primary asset, the Silver Sand project, has the potential to become one of the largest silver mines globally, supported by robust economic assessments. Additionally, the company is progressing its Carangas project, a silver-lead-zinc deposit with scale.

New Pacific Metals aims to create long-term value for its shareholders by advancing and de-risking its quality silver assets while contributing to the economic growth of Bolivia.

New Pacific Metals is headquartered in Vancouver, British Columbia, Canada.

Projects

Silver Sand Project

The flagship Silver Sand project is a high-grade silver deposit with an expected mine life of 13 years. A preliminary feasibility study (“PFS”) completed in June 2024 estimates an annual production of 12 million ounces of silver, including 15 million ounces in the first three years of operation, with total projected production reaching 157 million ounces. The project has a post-tax net present value (“NPV5%”) of $740 million at a silver price of $24 per ounce and an internal rate of return (“IRR”) of 37%. With a low all-in sustaining cost (“AISC”) of $10.69 per ounce and a 1.9-year payback period, Silver Sand presents a rare and compelling silver opportunity.

Carangas Project

The Carangas project is an emerging silver-lead-zinc deposit with a 16-year mine life. A preliminary economic assessment (“PEA”) completed in September 2024 indicates an annual production of 6.6 million ounces of silver, with total production projected at 106 million ounces. The project boasts an after-tax NPV5% of $501 million, an IRR of 26%, and a payback period of 3.2 years at $24 per ounce silver. Its low AISC of $7.60 per ounce positions Carangas as a high-margin operation with significant upside potential. The PEA preserves Carangas’ significant gold (1+ million ounces) potential at depth.

Market Opportunity

The global silver market continues to see increasing demand driven by industrial applications, investment interest, and the growing use of silver in renewable energy technologies. Bolivia, ranked as the fourth-largest silver-producing country, presents significant untapped potential due to limited modern exploration.

The Silver Sand and Carangas projects represent two of the largest undeveloped open-pit silver projects in the world, with the potential to deliver substantial production volumes. As silver prices remain favorable and demand continues to rise, New Pacific Metals is positioned to play a crucial role in supplying the global silver market.

Leadership Team

Dr. Rui Feng, Founder, is a geologist and entrepreneur with over 25 years of experience in mineral exploration and project development. In 2003, Dr. Feng founded Silvercorp, acquiring early-stage properties in China. Through discovery and development, Silvercorp has become one of the most profitable Canadian mining companies, with multiple mines in China. Building on that success, Dr. Feng established New Pacific Metals, where he has been instrumental in the discovery and advancement of its key projects. With a track record of building successful mining ventures, he continues to provide strategic insight to the company’s growth initiatives.

Jalen Yuan, Interim CEO, is a corporate leader and professional accountant with over sixteen years of diverse international experience in the mining industry.  Mr. Yuan has been deeply involved in all of the company’s strategic decisions as Chief Financial Officer since 2015, including those related to the acquisition, exploration, technical studies, and permitting of the Silver Sand and Carangas projects in Bolivia, prior to his appointment as Interim Chief Executive Officer in April 2025. Mr. Yuan also played instrumental roles in the company’s financing activities, raising a total of US$130 million since 2017.

Dickson Hall, Chairman of the Board of Directors, has over 40 years of experience in finance and corporate development, with a strong emphasis on the mining sector. He is a Partner at Valuestone Advisors Limited, sole advisor of Valuestone Global Resource Fund 1, and a director of Bunker Hill Mining Corp. and MEC Advisors Limited. Fluent in Mandarin and well-experienced in Chinese business culture, Mr. Hall has worked with an extensive group of multinationals, trade associations, and government organizations with China operations. He is a graduate of the University of British Columbia.

For more information, visit the company’s website at www.NewPacificMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in New Pacific Metals Corp. NEWP | Leave a comment

MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership

Posted on June 25, 2025 by MissionIR

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to urine and saliva tests, delivering results in under 10 minutes and gaining traction in sectors like logistics, education, and criminal justice. Spjotgard’s growing regional presence and strategic alliances position INBS to scale further in Northern Europe.

To view the full article, visit https://ibn.fm/PJPCa

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Intelligent Bio Solutions Inc. INBS | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Partners with Yonsei University and Incheon City to Advance Quantum Adoption in South Korea

Posted on June 24, 2025 by MissionIR
  • The three parties signed an MOU focusing on research collaboration, education, and commercial use case development.
  • MOU facilitates the organizations’ efforts towards the acquisition of a D-Wave Advantage2(TM) system at the Yonsei University International Campus.
  • The collaboration aims to advance mutual research and talent development for quantum computing, provide access to D-Wave’s quantum computing technology, and explore the development of use cases in biotechnology, materials science and other areas.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has entered into a strategic partnership with Yonsei University and Incheon Metropolitan City designed to accelerate quantum computing adoption and commercialization in South Korea. The company announced the signing of a memorandum of understanding (“MOU”) on June 17, outlining plans for quantum computing research, education, and collaboration (https://ibn.fm/0NaSv).

A central aim of the initiative is to facilitate the acquisition of a D-Wave Advantage2 system at Yonsei University’s International Campus in Songdo, Incheon. Installing such a system in South Korea would mark a step forward in the region’s broader quantum infrastructure ambitions. Under the terms of the MOU, the parties plan to also explore quantum computing’s potential use cases in sectors such as biotechnology and materials science. 

The partnership follows the recent announcement of general availability of the Advantage2 quantum computing system, which marked the release of what the company calls its most performant system yet, delivering energy-efficient, scalable quantum processing capable of tackling some problems that are beyond the capabilities of classical computing. The system features more than 4,400 qubits and is available through D-Wave’s Leap(TM) real-time quantum cloud service and for on-premises deployment by enterprises and research institutions.

“This collaboration with D-Wave and Incheon Metropolitan City supports our mission to facilitate a collaborative ecosystem for quantum computing literacy, research and commercial application development,” said Dong-Sup Yoon, president of Yonsei University. Yoon added that having a D-Wave annealing quantum computer onsite would offer “significant opportunities to advance industry and research in South Korea.”

For Incheon Metropolitan City, the MOU aligns with broader ambitions to become a global technology hub. “We have a unique opportunity to establish Incheon as a global quantum hub,” said Mayor Yoo Jeong-bok, citing the region’s established strengths in the bio industry and its potential to attract global quantum talent. “Building on Incheon’s strengths in the bio industry and other key sectors, we anticipate the emergence of a true quantum cluster where quantum technology converges with various industries to create innovative breakthroughs and attract top talent from around the world,” the mayor added.

According to Dr. Alan Baratz, CEO of D-Wave, the initiative represents both a regional and international milestone. “This strategic relationship marks an important step in furthering D-Wave’s mission to accelerate global quantum computing adoption,” said Dr. Baratz. “Yonsei University and Incheon Metropolitan City recognize the remarkable, immediate opportunity for scientific breakthroughs and business transformation possible with D-Wave’s quantum computing technology. We look forward to the possibility of installing a system at Yonsei University to further establish its role as a global quantum hub.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

Posted on June 24, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA underway for NRX-100 and additional regulatory filings in progress. The company also launched HOPE Therapeutics, a subsidiary focused on building a national psychiatric care network, with plans for a public spin-out. IBN will leverage its extensive media portfolio to expand investor awareness and outreach.

To view the full press release, visit https://ibn.fm/L8kUd

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Acquires Nautical Ventures to Launch First Integrated Electric Boat Dealership in North America

Posted on June 23, 2025 by MissionIR

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion, has acquired Nautical Ventures Group, a top U.S. boat dealership and 2024 Boating Industry “Dealer of the Year.” The move establishes North America’s first combined electric boat propulsion and dealership platform, pairing Vision Marine’s E-Motion(TM) powertrain with Nautical Ventures’ extensive retail network, inventory, and service capabilities.

With nine Florida locations and a portfolio that includes brands like Axopar, Yamaha, and Beneteau, Nautical Ventures provides Vision Marine direct access to one of the world’s most active boating markets. The acquisition adds direct-to-consumer capabilities, expanded revenue streams, and positions the company to scale nationwide. Funded through cash, a seller’s note, and stock, the deal was advised by ThinkEquity.

To view the full press release, visit https://ibn.fm/mXD9w

About Vision Marine Technologies Inc.
Vision Marine Technologies Inc. (NASDAQ: VMAR) is a leading innovator in high-voltage electric propulsion systems for the recreational marine industry. The Company’s E-Motion™ powertrain offers OEMs and consumers a scalable, zero-emission, high-performance alternative to internal combustion systems. Vision Marine’s mission is to transform the boating experience through technology, efficiency, and integrated end-to-end electric solutions. Visit:www.visionmarinetechnologies.com

NOTE TO INVESTORS: The latest news and updates relating to VMAR are available in the company’s newsroom at https://ibn.fm/VMAR

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Vision Marine Technologies Inc. VMAR | Leave a comment

Vivakor Inc. (NASDAQ: VIVK): A Modern Answer to Oil’s Dirty Problem

Posted on June 23, 2025 by MissionIR
  • Vivakor’s Q1 2025 revenue soared 133% year-over-year to $37.3 million
  • The company announced a special dividend to shareholders, distributing shares in Adapti Inc. as part of a non-cash value initiative
  • Vivakor specializes in sustainable energy transport, reuse, and remediation, critical as oil demand persists and environmental urgency rises

Despite growing investment in renewable energy, the world continues to run on oil and will for decades to come. From manufacturing solar panels to powering global transport, fossil fuels remain deeply embedded in every corner of industrial life. But as the environmental toll of this dependency grows harder to ignore, a middle path is gaining momentum: sustainably managing the dirty byproducts of oil while continuing to support energy demand. That’s exactly where Vivakor (NASDAQ: VIVK) has carved its niche; offering integrated solutions that transport, store, reuse, and remediate energy materials across the U.S.

A Record Start 

Vivakor kicked off the year with impressive momentum, reporting a 133% increase in revenue to $37.3 million for Q1 2025. Gross profit jumped 345% to $4.8 million, supported by a healthy gross margin of 12.7%. The lion’s share of revenue came from terminaling and storage services ($23.8 million), while transportation logistics, including related-party operations, contributed $13.5 million.

CEO James Ballengee attributed the performance to Vivakor’s strong long-term contracts and operational adjustments amid global uncertainties, including softening crude prices. “Our midstream assets—vehicles, trailers, pipelines, terminals—are contracted at the highest revenue levels in our company’s history,” said Ballengee. “We anticipate further expansion to support increasing demand.”

While Vivakor posted an operating loss of $6.4 million for the quarter, this figure included $8.2 million in non-cash expenses such as depreciation, amortization, and asset disposition. The company’s adjusted EBITDA turned positive, reaching $319,000 compared to a slight loss a year earlier.

Vivakor ended the quarter with $248.2 million in total assets and $108.8 million in stockholders’ equity, underscoring its growing footprint in the U.S. energy infrastructure landscape.

Sustainable Energy Services 

Vivakor doesn’t promise a fossil-free utopia; it offers tangible solutions to modern energy problems. Operating one of the largest oilfield trucking fleets in the continental U.S., the company plays a central role in safely moving, storing, and processing crude oil and oilfield waste. Its remediation facilities are built to recover, reuse, and dispose of petroleum byproducts with minimal environmental impact.

This model not only supports existing energy infrastructure but also provides a cleaner, more responsible way to manage oil’s lifecycle. As solar and wind buildouts accelerate, the irony remains: they rely on oil at nearly every stage, from raw material extraction to panel deployment. Until a true fossil fuel alternative emerges, companies like Vivakor that handle the “messy middle” will be critical players.

Creating Value Beyond the Core Business

In addition to its operational achievements, Vivakor also made headlines by announcing a special dividend for shareholders. The dividend consists of shares in Adapti Inc., a tech firm that leverages AI to match products with influencers through its AdaptAI platform.

Vivakor owns roughly 206,595 shares in Adapti (approximately 13.5% of its outstanding common stock) and will distribute a portion of that equity to shareholders, excluding shares held by Vivakor executives who have waived their right to participate. Based on current valuations, the dividend is worth approximately $0.815 million.

This move not only rewards investors but highlights Vivakor’s non-traditional approach to value creation, using owned equity stakes in outside ventures as an asset strategy.

Positioned for a New Era of Energy Accountability

The energy transition isn’t just about replacing oil. It’s about managing its risks, cleaning up its footprint, and building systems that are both scalable and sustainable. Vivakor’s end-to-end platform fits neatly into this reality, offering a responsible solution in a world that still runs on hydrocarbons.

From rising revenues to shareholder-friendly policies, Vivakor is proving that cleaner energy services and solid business performance don’t have to be mutually exclusive. And as 2025 unfolds, the company looks well-positioned to continue growing its reach, while helping the oil-driven world we inherited operate more sustainably.

For more information, visit the company’s website at Vivakor.com.

NOTE TO INVESTORS: The latest news and updates relating to VIVK are available in the company’s newsroom at https://ibn.fm/VIVK

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Vivakor Inc. VIVK | Leave a comment